Issued Patents All Time
Showing 1–25 of 33 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12252530 | Human antibodies to Fel d1 and methods of use thereof | Andrew J. Murphy | 2025-03-18 |
| 12037388 | Anti-IL-33 antibodies and uses thereof | Andrew J. Murphy, Nicholas J. Papadopoulos | 2024-07-16 |
| 11964016 | Combination of IL-4/IL-13 pathway inhibitors and plasma cell ablation for treating allergy | Seblewongel ASRAT, Andre Limnander, Andrew J. Murphy, George D. Yancopoulos | 2024-04-23 |
| 11897945 | Methods of treating allergy using anti-Bet v 1 antibodies | Amanda Atanasio, Gary Herman, Meagan P. O'Brien, Lorah Perlee | 2024-02-13 |
| 11866503 | Methods for treating inflammatory conditions of the airway or lungs by administering antagonist monoclonal antibodies to interleukin-33 and interleukin-4 receptor | Jeanne Allinne, Andrew J. Murphy, George D. Yancopoulos | 2024-01-09 |
| 11767358 | Human antibodies to Bet v 1 and methods of use thereof | Andrew J. Murphy, Ashok T. Badithe, Vishal Kamat, Yashu Liu | 2023-09-26 |
| 11629195 | Anti-IL2 receptor gamma antigen-binding proteins | Andrew J. Murphy | 2023-04-18 |
| 11578127 | Anti-Fc epsilon-R1 alpha (FcεR1α) antibodies, bispecific antigen-binding molecules that bind FcεR1α and CD3, and uses thereof | Andre Limnander, Jee H. Kim, Andrew J. Murphy | 2023-02-14 |
| 11542326 | Anti-IL-25 antibodies and uses thereof | Jeanne Allinne | 2023-01-03 |
| 11485788 | Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R inhibitor | Neil Stahl, Andrew J. Murphy, Namita A. Gandhi, Neil Graham | 2022-11-01 |
| 11352417 | Method of treating an allergy with allergen-specific monoclonal antibodies | Namita A. Gandhi, Allen Radin, Ana Kostic, Andrew J. Murphy, George D. Yancopoulos | 2022-06-07 |
| 11174305 | Human antibodies to Fel d1 and methods of use thereof | Andrew J. Murphy | 2021-11-16 |
| 11104729 | Anti-IL-33 antibodies and uses thereof | Andrew J. Murphy, Nicholas J. Papadopoulos | 2021-08-31 |
| 10935554 | Diagnostic tests and methods for assessing safety, efficacy or outcome of allergen-specific immunotherapy (SIT) | George D. Yancopoulos | 2021-03-02 |
| 10851158 | Biomarkers related to interleukin-33 (IL-33)-mediated diseases and uses thereof | Jeanne Allinne, Wen Fury, Yu Sheng Bai | 2020-12-01 |
| 10815305 | Methods of treating inflammatory conditions | Jeanne Allinne, Andrew J. Murphy, George D. Yancopoulos | 2020-10-27 |
| 10793624 | Human antibodies to Bet v 1 and methods of use thereof | Andrew J. Murphy, Ashok T. Badithe, Vishal Kamat, Yashu Liu | 2020-10-06 |
| 10774128 | IL-33 antagonists and uses thereof | Andrew J. Murphy, Nicholas J. Papadopoulos | 2020-09-15 |
| 10676530 | Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an antibody to IL-4 receptor | Neil Stahl, Andrew J. Murphy, Namita A. Gandhi, Neil Graham | 2020-06-09 |
| 10669341 | Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an antibody to IL-4 receptor | Neil Stahl, Andrew J. Murphy, Namita A. Gandhi, Neil Graham | 2020-06-02 |
| 10640558 | Anti-IL-25 antibodies and uses thereof | Jeanne Allinne | 2020-05-05 |
| 10519230 | Nucleic acids encoding IL-33 antibodies | Andrew J. Murphy, Nicholas J. Papadopoulos | 2019-12-31 |
| 10392439 | Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R inhibitor | Neil Stahl, Andrew J. Murphy, Namita A. Gandhi, Neil Graham | 2019-08-27 |
| 10047152 | Human antibodies to fel D1 and methods of use thereof | Andrew J. Murphy | 2018-08-14 |
| 10047153 | Human antibodies to Fel d1 and methods of use thereof | Andrew J. Murphy | 2018-08-14 |